17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A<br />

B<br />

Fig. 1.09 Mammographic demonstration of the evolution of a poorly differentiated invasive ductal <strong>carcinoma</strong>, a circular tumour mass on the mammogram.<br />

A Non-specific density in the axillary tail of the right <strong>breast</strong>, undetected at screening. B 18 Months later: >30 mm ill defined, high density lobulated tumour, mammographically<br />

malignant. Metastatic lymph nodes are seen in the axilla. C Large section histology of the tumour.<br />

C<br />

masses, parenchymal deformity and calcification<br />

with or without a mass lesion.<br />

By far the most common manifestation of<br />

<strong>breast</strong> cancer on the mammogram is<br />

tumour mass without calcifications. The<br />

mammographic histological corre l a t i o n<br />

of 1,168 open surgical biopsies at Falun<br />

Central Hospital, Sweden, included 866<br />

Table 1.03<br />

Mammographic appearance of histologically<br />

malignant <strong>breast</strong> lesions.<br />

Stellate and circular 64%<br />

without calcifications<br />

Stellate and circular 17%<br />

with calcifications<br />

Calcifications only 19%<br />

Table 1.04<br />

Spectrum of histological diagnosis corresponding<br />

to mammographic circular/oval lesions.<br />

<strong>Invasive</strong> ductal <strong>carcinoma</strong>, NOS 59%<br />

Medullary <strong>carcinoma</strong> 8%<br />

Mucinous <strong>carcinoma</strong> 7%<br />

Intracystic <strong>carcinoma</strong> 5%<br />

Tubular <strong>carcinoma</strong> 4%<br />

<strong>Invasive</strong> lobular <strong>carcinoma</strong> 4%<br />

Other diagnoses 13%<br />

histologically proven malignancies. As<br />

seen in Table 1.03, the mammograms of<br />

these <strong>breast</strong>s cancer showed:<br />

1) Stellate or circular tumour mass with<br />

no associated calcifications in 64% of the<br />

cases.<br />

2) An additional 17% had both calcifications<br />

and tumour mass.<br />

3) Only calcifications without associated<br />

tumour mass accounted for less than<br />

20% of all malignancies detectable on<br />

the mammogram.<br />

Grading of invasive <strong>carcinoma</strong><br />

<strong>Invasive</strong> ductal <strong>carcinoma</strong>s and all other<br />

invasive tumours are routinely graded<br />

based on an assessment of tubule/gland<br />

f o rmation, nuclear pleomorphism and<br />

mitotic counts.<br />

Many studies have demonstrated a significant<br />

association between histological<br />

grade and survival in invasive <strong>breast</strong> <strong>carcinoma</strong>.<br />

It is now recognized as a powerful<br />

prognostic factor and should be<br />

included as a component of the minimum<br />

data set for histological re p o rting of<br />

<strong>breast</strong> cancer {779,1190}. Assessment of<br />

histological grade has become more<br />

objective with modifications of the Patley<br />

& Scarff {2195} method first by Bloom<br />

and Richardson {293} and more recently<br />

by Elston and Ellis {777,2385}.<br />

Method of grading<br />

T h ree tumour characteristics are evaluated;<br />

tubule formation as an expression of<br />

glandular diff e rentiation, nuclear pleomorphism<br />

and mitotic counts. A numerical<br />

scoring system of 1-3 is used to ensure<br />

that each factor is assessed individually.<br />

When evaluating tubules and glandular<br />

acini only structures exhibiting clear central<br />

lumina are counted; cut off points of<br />

75% and 10% of glandular/tumour area<br />

are used to allocate the score.<br />

Nuclear pleomorphism is assessed by<br />

reference to the regularity of nuclear size<br />

and shape of normal epithelial cells in<br />

adjacent <strong>breast</strong> tissue. Increasing irregularity<br />

of nuclear outlines and the number<br />

and size of nucleoli are useful additional<br />

features in allocating scores for pleomorphism.<br />

Evaluation of mitotic figures requires care<br />

and observers must count only defined<br />

mitotic figures; hyperc h romatic and<br />

pyknotic nuclei are ignored since they<br />

are more likely to represent apoptosis<br />

than proliferation. Mitotic counts require<br />

standardization to a fixed field area or by<br />

using a grid system {1984}. The total<br />

number of mitoses per 10 high power<br />

fields. Field selection for mitotic scoring<br />

should be from the peripheral leading<br />

edge of the tumour. If there is heterogeneity,<br />

regions exhibiting a higher frequency<br />

of mitoses should be chosen.<br />

Field selection is by random meander<br />

through the chosen area. Only fields with<br />

a re p resentative tumour cell burd e n<br />

should be assessed.<br />

The three values are added together to<br />

produce scores of 3 to 9, to which the<br />

grade is assigned as follows:<br />

18 Tumours of the <strong>breast</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!